China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Resources Pharmaceutical Group Ltd., through its subsidiary CR Pharmaceutical Commercial, has issued RMB3 billion worth of perpetual bonds in the PRC, aimed at repaying existing corporate bonds. With a top-tier ‘AAA’ rating from China Chengxi International Credit Ratings, the bonds come in two varieties, offering a three-year term at 2.15% and a five-year term at 2.26% per annum.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.